Follow the SyntheticMR AB (publ) share price and the full directors' dealings record of the company, a listed equity based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, SyntheticMR AB (publ) has published 1 public disclosures. Market capitalisation: €71.3m. The latest transaction was reported on 4 February 2026 (Purchase). Among the most active insiders: Gisli Hennermark. The full history is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration